Recursion Pharmaceuticals (RXRX) Q1 2025 Earnings

Feb 28Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.53
-0.46
-0.4
-0.33

Details

Expected EPS
-0.411429
Actual EPS
-0.53
Surprise EPS
-0.12
Surprise Percent
-28.82%

Description

⁨Recursion Pharmaceuticals⁩ (⁦RXRX⁩) has reported earnings of ⁦-0.53⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts